title: [Late complications after treatment of Hodgkin's disease].
abstract: Treatment of Hodgkin's disease involves chemotherapy and radiation. Both modalities may cause cardiac, pulmonary and thyroid side-effects. In a cross-sectional study, we aimed to assess the occurrence and severity of such complications. From 1980 to 1989, 129 Norwegian patients (< 50 years old) had curative treatment for Hodgkin's disease 116 (90%) of them participated in the study (follow-up period 5-13 years). Methods included lung function tests, chest X-rays, bicycle exercise tests, echocardiography and thyroid function tests. Nearly 30% of the patients reported dyspnoea on exertion and had associated reductions in lung function. Evidence of fibrosis occurred in 68%, but was associated with reduced lung function in only 12%. Pathological left-sided heart valve regurgitations were detected in 24% of the patients, pericardial thickening in 15%, and coronary artery disease in 5%. Biochemical hypothyreosis was found in 67% of the patients. We conclude that cardiac, pulmonary and thyroid dysfunctions are frequent long-term side-effects after treatment for Hodgkin's disease. We recommend annual screening of thyroid function and echocardiographic examination in patients who have received standard mantle field radiotherapy without cardiac shielding. Lung function testing should be done in individuals who require further radiation, chemotherapy or thoracic surgery.
authors.affiliation: Lungeavdelingen, Det Norske Radiumhospital, Oslo.
authors.forename: M B
authors.initials: MB
authors.lastname: Lund
authors.forename: J
authors.initials: J
authors.lastname: Kongerud
authors.forename: J
authors.initials: J
authors.lastname: Boe
authors.forename: H
authors.initials: H
authors.lastname: Ihlen
authors.forename: K
authors.initials: K
authors.lastname: Forfang
authors.forename: A F
authors.initials: AF
authors.lastname: Abrahamsen
authors.forename: O
authors.initials: O
authors.lastname: Nome
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000009:adverse effects*; D003131:Combined Modality Therapy; D003430:Cross-Sectional Studies; D005260:Female; D005500:Follow-Up Studies; D006331:Heart Diseases / Q000175:diagnosis / Q000209:etiology*; D006689:Hodgkin Disease / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D006801:Humans; D008171:Lung Diseases / Q000175:diagnosis / Q000209:etiology*; D008297:Male; D008875:Middle Aged; D011878:Radiotherapy / Q000009:adverse effects*; D012129:Respiratory Function Tests; D013959:Thyroid Diseases / Q000175:diagnosis / Q000209:etiology; D013960:Thyroid Function Tests
chemical_list: D000970:Antineoplastic Agents